Answers are grounded in this paper and cite their sources.
In patients with stage 4 or 5 chronic kidney disease or end-stage renal disease who received gadolinium-based contrast agents since 2010, diagnostic codes for potential nephrogenic systemic fibrosis or mimics were exceedingly rare.
No takes yet. Share an insight, caveat, or question.
Mallepally et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: